)
)
Entera Bio Investor Relations Material
Latest events
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Entera Bio Ltd
Access all reports
Entera Bio Ltd. is a biotechnology company focused on the development of oral drug formulations for conditions traditionally treated with injectable therapies. The company specializes in proprietary oral delivery technology to improve the bioavailability of large molecules, such as peptides and proteins. Entera Bio’s research targets metabolic and endocrine disorders, including osteoporosis and hypoparathyroidism. The company is headquartered in Jerusalem, Israel, and its shares are listed on the NASDAQ.
Key slides for Entera Bio Ltd
Corporate Presentation
Entera Bio Ltd
Corporate Presentation
Entera Bio Ltd
Latest articles
)
Robert G. Hagstrom: Darwinian Investing and Multidisciplinary Wisdom
Robert G. Hagstrom, author of The Warren Buffett Way, explores how interdisciplinary thinking shapes his investing, from Adler's reading to Darwinian markets.
7 Feb 2025
)
Quartr Brings Stories Behind the Numbers to Light
Quartr simplifies access to IR material and puts qualitative insights and company narratives front and center.
3 Feb 2025
)
The Evolution of the IRO Role: Staying Informed and Strategic With Quartr Pro
Staying informed is critical for IROs. Quartr Pro simplifies gathering market insights and narrative positioning with unprecedented speed and precision.
3 Feb 2025
Ticker symbol
ENTX
Country
🇺🇸 United States